The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
about
Prevention of Alzheimer's diseaseAntihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individualsAngiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney diseasePharmacotherapy for hypertension in the elderlyBlood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementiaAngiotensin receptor blockers and myocardial infarctionDifferential clinical profile of candesartan compared to other angiotensin receptor blockersEffects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second StrokesVascular risk factors and dementia: how to move forward?Alzheimer disease: epidemiology, diagnostic criteria, risk factors and biomarkersAngiotensin receptor blockers for prevention of cardiovascular disease: where does the evidence stand?Heart failure and Alzheimer's diseaseEpidemiology of Alzheimer diseaseMild cognitive impairment and dementia: the importance of modifiable risk factorsManaging hypertension in the elderly: a common chronic disease with increasing ageAngiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patientsDrug repositioning approaches for the discovery of new therapeutics for Alzheimer's diseaseIs blood pressure reduction a valid surrogate endpoint for stroke prevention? An analysis incorporating a systematic review of randomised controlled trials, a by-trial weighted errors-in-variables regression, the surrogate threshold effect (STE) andModulation of glucose metabolism by the renin-angiotensin-aldosterone systemThe treatment of hypertension in people with dementia: a systematic review of observational studiesPrevention and intervention studies with telmisartan, ramipril and their combination in different rat stroke modelsHypertension and cognitive dysfunction in elderly: blood pressure management for this global burdenEffects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Prothrombotic Processes and Myocardial Infarction RiskCan angiotensin-converting enzyme inhibitors impact cognitive decline in early stages of Alzheimer's disease? An overview of research evidence in the elderly patient populationPrimary prevention: do the very elderly require a different approach?Fixed combination of losartan and hydrochlorothiazide and reduction of risk of strokeRole of angiotensin II in cardiovascular disease therapeutic implications of more than a century of researchProgressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trialChecking the STEP-Associated Trafficking and Internalization of Glutamate Receptors for Reduced Cognitive Deficits: A Machine Learning Approach-Based Cheminformatics Study and Its Application for Drug RepurposingAngiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research DatabaseDefining the Relationship Between Hypertension, Cognitive Decline, and Dementia: a Review.Comparing angiotensin II receptor blockers on benefits beyond blood pressureFrom hypertension to stroke: mechanisms and potential prevention strategies.Diuretic use is associated with better learning and memory in older adults in the Ginkgo Evaluation of Memory Study.A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitorsComparative effectiveness of antihypertensive medication for primary prevention of cardiovascular disease: systematic review and multiple treatments meta-analysis.Salt intake and cardiovascular disease: why are the data inconsistent?Biomarkers of cerebrovascular disease in dementia.Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall.Hypertension, cognitive decline, and dementia: an epidemiological perspective
P2860
Q22248031-187532F9-19EF-4A51-AAEB-7C6B83B8877FQ24186039-EA04FA66-29FD-4474-ACFC-B5A55FDAFF03Q24235834-225EE7A3-05E5-4A30-95A2-A4634617C076Q24240189-3F5FED24-4874-443B-BF47-00CB431C4950Q24240206-DDB3766C-828C-4423-967D-F8F1631B9F3FQ24559659-3FF5FAD6-78F3-4326-AF15-8F3A3960A35CQ24613321-A1BEDFD4-7A08-4D21-9D80-7474A7B49091Q24645205-914FC0F1-1A3C-478F-98B7-F572E2E66484Q24650263-D7DB47E7-2FDF-4803-8967-AB2E09A21882Q26825442-26C48EAA-7FA6-4F23-AF23-0A80E04E68F0Q26851803-96F7C265-BEE0-494F-A629-2DA02F4DA34AQ26852526-487E73EB-E24A-4E48-903E-C436726BC769Q26865371-88AE281F-FFAC-4B5D-AB5E-D1E2BAF5AF08Q26994975-8CFCC765-6679-4A5F-A556-CEA8B1FBAECDQ27011805-BBDDA604-A9AE-48FB-89B6-A79594E0FB01Q27023161-D4D5E3B5-A49A-4678-8435-A18A054F35C8Q27024122-5D93F95D-AE2D-4E1A-8E19-FAD544E8D9CAQ27025943-EB3CF717-AE57-4C66-A079-5562BE7FE955Q27026157-85119632-EFDE-43B3-8BC9-87E58379A275Q27026345-1B0A7BCB-2C81-445E-B3E1-6B114438789FQ27323835-22EB01E6-E607-455D-B24C-6F06B5EC9AF4Q28074728-8C2A83C0-3E66-4287-88DE-DA2E681AEC48Q28076223-5CCAFE7F-46C8-48E4-9CBA-53FCE8B4CDDEQ28077087-0B201D69-AB30-46DA-9405-9DAE8054AAA0Q28080456-3EDE501C-F51F-4F4C-AEF2-6603F24307F4Q28219593-716CDA22-90A4-4B0C-983C-B64C1D480950Q28272171-425D709D-62BF-44F3-9D38-5FAFE5DB59BCQ28286410-EA9B414F-6BC5-4F3E-B864-BB8CE52205A4Q28548306-3251B1AF-5B66-4DFE-A2BD-FD02280AABA1Q28730234-D60E133C-7FEB-4D28-9AD6-D2A31649A746Q30235254-66B41AD9-DE06-46BE-B659-FB643B04F2C2Q30360678-401752E8-7D11-460A-917A-7EBD4446051AQ30407495-4819358F-2B05-4E08-9B07-9D1EE9030D96Q30419458-BA564FF9-E69A-4C05-8975-F24C4ABBC75EQ30432209-863778C2-CA14-4343-A4FD-9D6E4C76347FQ30514101-0BE69252-1384-419E-A428-ED64999DDD57Q30582625-3B7CB104-7C72-473D-9F9E-7D49BEA34C1AQ31153979-E3F11824-FF76-4AC9-9179-BF85E00F49FEQ33239013-9DD0898F-C241-40C0-96F9-D29F2334E4FFQ33284785-E5DA1CF2-E72B-484B-B22F-525BF0D81D06
P2860
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
The Study on Cognition and Pro ...... uble-blind intervention trial.
@en
The Study on Cognition and Prognosis in the Elderly
@nl
type
label
The Study on Cognition and Pro ...... uble-blind intervention trial.
@en
The Study on Cognition and Prognosis in the Elderly
@nl
prefLabel
The Study on Cognition and Pro ...... uble-blind intervention trial.
@en
The Study on Cognition and Prognosis in the Elderly
@nl
P2093
P1476
The Study on Cognition and Pro ...... uble-blind intervention trial.
@en
P2093
Alberto Zanchetti
Bertil Olofsson
Dag Elmfeldt
Hans Lithell
Ingmar Skoog
Lennart Hansson
Peter Trenkwalder
SCOPE Study Group
P304
P356
10.1097/00004872-200305000-00011
P577
2003-05-01T00:00:00Z